Get started
Author

Daniele Lavacchi

Observed names: D. Lavacchi, D., Lavacchi, DANIELE LAVACCHI, Lavacchi Daniele, Lavacchi, Daniele
OpenAlex ID: A5069705709
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
2020 · Giandomenico Roviello, Alberto D'Angelo, et al. · Translational Oncology · 124
PDF
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data
2023 · Margherita Rimini, Lorenzo Fornaro, et al. · Liver International · 114
PDF
MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
2020 · Maria Grazia Rodriquenz, Giandomenico Roviello, et al. · Journal of Clinical Medicine · 77
PDF
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
2024 · Margherita Rimini, Lorenzo Fornaro, et al. · European Journal of Cancer · 59
Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives
2019 · Daniele Lavacchi, Francesca Mazzoni, et al. · Drug Design Development and Therapy · 59
PDF
Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
2020 · Daniele Lavacchi, Elisa Pellegrini, et al. · International Journal of Molecular Sciences · 54
PDF
Results of the observational prospective RealFLOT study
2021 · Elisa Giommoni, Daniele Lavacchi, et al. · BMC Cancer · 47
PDF
Tumor-Agnostic Treatment for Cancer: When How is Better than Where
2020 · Daniele Lavacchi, Giandomenico Roviello, et al. · Clinical Drug Investigation · 41
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
2021 · Agnese Paderi, Elisabetta Gambale, et al. · Molecules · 34
PDF
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
2022 · Daniele Lavacchi, Enrico Caliman, et al. · Pharmacology & Therapeutics · 32
PDF
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
2023 · Floriana Nappo, Lorenzo Fornaro, et al. · Journal of Cancer Research and Clinical Oncology · 28
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
2024 · Margherita Rimini, Gianluca Masi, et al. · Targeted Oncology · 27
PDF
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
2022 · Daniele Lavacchi, Sara Fancelli, et al. · Frontiers in Oncology · 27
PDF
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy
2022 · Enrico Caliman, Sara Fancelli, et al. · Cancer Treatment and Research Communications · 25
PDF
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer
2021 · Giovanni Randon, Rossana Intini, et al. · European Journal of Cancer · 24
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study
2020 · Melissa Bersanelli, Sebastiano Buti, et al. · Lung Cancer · 24
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
2019 · G. Roviello, F. U. Conter, et al. · Cancer Chemotherapy and Pharmacology · 24
PDF
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience
2023 · Margherita Rimini, Valentina Burgio, et al. · Therapeutic Advances in Medical Oncology · 20
PDF
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
2021 · Daniele Lavacchi, Ida Landini, et al. · Pharmacology & Therapeutics · 20
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience
2019 · Stefania Nobili, Daniele Lavacchi, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 19
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm?
2024 · Jacopo Venturini, Giulia Massaro, et al. · Critical Reviews in Oncology/Hematology · 16
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study
2026 · Veronica Conca, Daniele Rossini, et al. · Journal of Clinical Oncology · 15
PDF
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer
2023 · Daniele Lavacchi, Giandomenico Roviello, et al. · International Journal of Molecular Sciences · 15
PDF
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
2023 · Daniele Lavacchi, Sara Fancelli, et al. · International Journal of Molecular Sciences · 15
PDF
Electronic nicotine delivery systems (ENDS): not still ready to put on END
2020 · Daniele Lavacchi, Giandomenico Roviello, et al. · Journal of Thoracic Disease · 14
PDF
Works count: 124
Citation count: 1,232
H-index: 19
I10-index: 33
Year
Topic
Type